Catalyst Pharmaceuticals ... (CPRX)
NASDAQ: CPRX
· Real-Time Price · USD
20.23
0.16 (0.80%)
At close: Aug 15, 2025, 3:59 PM
20.15
-0.37%
After-hours: Aug 15, 2025, 07:54 PM EDT
Catalyst Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 652.8M | 580.66M | 517.55M | 442.33M | 375.69M | 310.41M | 137.64M | 120.97M | 178.79M | 148.25M | 298.39M | 256.06M | 210.91M | 178.37M | 171.44M | 154.84M | 135.29M | 127.33M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.88M | 19.42M | 19.82M | 19.96M | 19.98M | 15.97M |
Long-Term Investments | 21.26M | 24.21M | 21.56M | 14.84M | 13.08M | 15.35M | 16.49M | 12.9M | 179.44M | 188.07M | n/a | -20.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -179.44M | -188.07M | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 9K |
Receivables | 65.86M | 72.26M | 65.49M | 58.27M | 57.17M | 60.49M | 53.51M | 48.05M | 42.8M | 33.4M | 10.44M | 9.34M | 9.59M | 10.55M | 6.62M | 6.63M | 6.29M | 5.6M |
Inventory | 18.65M | 19.78M | 19.54M | 20.02M | 18.01M | 19.95M | 15.64M | 9.04M | 10.75M | 10.33M | 6.8M | 7.13M | 7.85M | 7.83M | 7.87M | 6.95M | 7.1M | 4.39M |
Other Current Assets | 21.43M | 452K | 1.04M | 18.38M | 1.14M | 1.68M | 489K | 352K | 361K | 548K | 931K | 790K | 611K | 665K | 432K | 425K | 3.24M | 680K |
Total Current Assets | 758.74M | 685.72M | 623.61M | 539M | 474.43M | 404.6M | 219.33M | 192.02M | 240.97M | 198.91M | 320.8M | 276.31M | 242.56M | 221.19M | 210.11M | 192.79M | 176.31M | 161.53M |
Property-Plant & Equipment | 3.23M | 3.4M | 3.58M | 3.68M | 3.6M | 3.75M | 3.7M | 3.76M | 3.84M | 3.99M | 3.62M | 3.71M | 3.81M | 3.88M | 3.98M | 4.04M | 4.12M | 4.25M |
Goodwill & Intangibles | 137.98M | 147.33M | 156.67M | 166.02M | 175.36M | 184.71M | 194.05M | 167.11M | 175.59M | 184.08M | 32.47M | 33.05M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 213.18M | 223.15M | 227.8M | 233.01M | 231.93M | 242.07M | 252.58M | 221.19M | 202.93M | 208.32M | 54.83M | 56.8M | 24.75M | 25.78M | 27.68M | 30.45M | 32.83M | 35.68M |
Total Assets | 971.91M | 908.87M | 851.41M | 772.01M | 706.36M | 646.68M | 471.91M | 413.21M | 443.9M | 407.23M | 375.63M | 333.11M | 267.31M | 246.97M | 237.79M | 223.25M | 209.13M | 197.22M |
Account Payables | 5.53M | 11.2M | 16.59M | 11.56M | 7.12M | 10.26M | 14.79M | 4.6M | 4.42M | 3.39M | 3.98M | 2.53M | 2.31M | 5.14M | 2.77M | 2.75M | 2.92M | 2.56M |
Deferred Revenue | n/a | n/a | n/a | n/a | 15K | 68.3M | 729K | 52.47M | 47.27M | n/a | n/a | 41.59M | n/a | n/a | 23.74M | 17.47M | 12.9M | 11.64M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 107.48M | 8.83M | 11.16M | 90.57M | 77.51M | 56.74M | 51.29M | 46.66M | 38.83M | 32.98M | 39.44M | 34.67M | 15.14M | 14.23M | 19.87M | 14.6M | 2.13M | 9.77M |
Total Current Liabilities | 113.01M | 111.65M | 120.68M | 105.39M | 92.32M | 79.57M | 76.06M | 57.81M | 52.5M | 56.71M | 57.59M | 44.68M | 22.49M | 22.94M | 27.06M | 20.61M | 16.14M | 14.44M |
Long-Term Debt | 2.57M | n/a | n/a | 2.89M | 2.99M | 3.09M | 3.19M | 3.28M | 3.38M | 3.47M | 3.56M | 3.64M | 3.73M | 3.81M | 3.89M | 3.97M | 4.05M | n/a |
Other Long-Term Liabilities | 309K | 259K | 315K | 2.79M | -595K | -484K | -206K | 293K | 9.35M | 9.92M | 10.51M | 11.11M | -3.73M | -3.81M | -3.89M | -3.97M | -4.05M | n/a |
Total Long-Term Liabilities | 2.88M | 2.94M | 3.1M | 5.67M | 5.39M | 5.7M | 7.96M | 6.86M | 16.1M | 16.86M | 17.62M | 18.39M | 3.73M | 3.81M | 3.89M | 3.97M | 4.05M | 4.13M |
Total Liabilities | 115.89M | 114.59M | 123.78M | 111.07M | 97.7M | 85.26M | 84.03M | 64.66M | 68.6M | 73.57M | 75.21M | 63.07M | 26.22M | 26.75M | 30.96M | 24.59M | 20.19M | 18.57M |
Total Debt | 2.57M | 3.09M | 3.19M | 3.28M | 3.38M | 3.47M | 3.56M | 3.64M | 3.73M | 3.47M | 3.89M | 3.97M | 4.05M | 4.13M | 3.89M | 4.25M | 4.25M | 4.25M |
Common Stock | 122K | 122K | 121K | 119K | 119K | 118K | 107K | 107K | 107K | 106K | 105K | 104K | 103K | 103K | 103K | 103K | 103K | 104K |
Retained Earnings | 394.01M | 341.9M | 285.16M | 229.22M | 185.34M | 144.55M | 121.27M | 86.43M | 117.19M | 79.43M | 49.86M | 24.39M | 1.64M | -15.62M | -26.31M | -32.54M | -37.82M | -46.34M |
Comprehensive Income | 31K | -17K | 64K | n/a | -0.00 | -0.00 | 14K | 15K | 19K | 11K | 24K | 32K | -130K | -453K | -148K | -63K | -37K | -45K |
Shareholders Equity | 856.03M | 794.28M | 727.63M | 660.94M | 608.65M | 561.41M | 387.88M | 348.55M | 375.29M | 333.66M | 300.42M | 270.04M | 241.09M | 220.22M | 206.83M | 198.66M | 188.94M | 178.65M |
Total Investments | n/a | 24.21M | 21.56M | 14.84M | 13.08M | 15.35M | 16.49M | 12.9M | 179.44M | 188.07M | n/a | n/a | 9.88M | 19.42M | 19.82M | 19.96M | 19.98M | 15.97M |